Joint (NASDAQ:JYNT) Major Shareholder Charles Jobson Acquires 2,825 Shares of Stock

The Joint Corp. (NASDAQ:JYNT) major shareholder Charles Jobson purchased 2,825 shares of Joint stock in a transaction on Tuesday, November 10th. The shares were acquired at an average price of $6.65 per share, with a total value of $18,786.25. Following the transaction, the insider directly owned 20,322,974 shares in the company, valued at $135,147,777.10. This trade represents a 0.01% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Joint Stock Performance

Shares of NASDAQ:JYNT traded up $0.25 on Friday, hitting $6.94. The company’s stock had a trading volume of 61,872 shares, compared to its average volume of 80,915. The company has a market capitalization of $95.01 million, a price-to-earnings ratio of 34.70 and a beta of 1.16. The Joint Corp. has a 12 month low of $6.52 and a 12 month high of $10.67. The stock’s 50-day moving average is $7.53 and its two-hundred day moving average is $8.47.

Joint (NASDAQ:JYNT) last issued its quarterly earnings data on Thursday, November 5th. The company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Joint had a net margin of 4.81% and a return on equity of 22.11%. The business had revenue of $13.55 million for the quarter, compared to analysts’ expectations of $14.85 million. Equities analysts expect that The Joint Corp. will post 0.31 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on JYNT shares. Wall Street Zen cut Joint from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. B. Riley Financial cut their price objective on Joint from $9.00 to $8.00 and set a “neutral” rating for the company in a research report on Monday. Finally, Weiss Ratings raised Joint from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday. Two equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus target price of $8.00.

Institutional Trading of Joint

Several large investors have recently added to or reduced their stakes in the company. R Squared Ltd lifted its holdings in shares of Joint by 40.3% in the third quarter. R Squared Ltd now owns 14,910 shares of the company’s stock valued at $110,000 after purchasing an additional 4,284 shares in the last quarter. Susquehanna International Group LLP boosted its position in shares of Joint by 161.3% in the second quarter. Susquehanna International Group LLP now owns 43,138 shares of the company’s stock worth $379,000 after buying an additional 26,626 shares during the period. Squarepoint Ops LLC grew its holdings in shares of Joint by 35.5% during the second quarter. Squarepoint Ops LLC now owns 105,467 shares of the company’s stock valued at $926,000 after buying an additional 27,633 shares in the last quarter. Verus Capital Partners LLC grew its holdings in shares of Joint by 23.6% during the first quarter. Verus Capital Partners LLC now owns 130,705 shares of the company’s stock valued at $1,157,000 after buying an additional 24,929 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Joint by 37.4% during the first quarter. Dimensional Fund Advisors LP now owns 153,754 shares of the company’s stock valued at $1,361,000 after buying an additional 41,842 shares in the last quarter. 76.88% of the stock is owned by institutional investors and hedge funds.

About Joint

The Joint Corp. operates and franchises The Joint Chiropractic, a network of clinics providing chiropractic care in the United States. Its clinics offer services such as spinal adjustments and other chiropractic treatments focused on musculoskeletal health and wellness. The company’s business model emphasizes convenient access to care, with options that include walk-in visits and recurring membership plans. The Joint Corp. was established in 2010 and is headquartered in Scottsdale, Arizona.